Preparing for 2020 launch of novel digital PCR systems with fully integrated workflow and menu of QIAGEN assays, advantages of improved multiplexing, throughput and scalability Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the development of a range of next-generation systems for digital polymerase chain reaction (digital PCR […]
Enhancing QIAGEN’s industry-leading position with access to MarkerMine™ database and real-world evidence insights that provide insights for targeted therapy options Redwood City, California, and Hilden, Germany – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today it has entered into an agreement to acquire N-of-One, Inc., a privately-held U.S. molecular decision support company and pioneer […]
SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced it has expanded its product portfolio to offer genes up to five kilobases (5kb) in length at industry-leading pricing. In addition, Twist is making its Application Programming Interface (Twist API or TAPI) available for all […]
SAN FRANCISCO — Today Color announced an initiative to help build the foundation for the first mainstream application of whole genome sequencing in clinical care, through the use of polygenic risk scores. Polygenic risk scoring can help clinicians identify populations who are at risk for diseases such as cancer and heart disease in order to optimize prevention […]
–Subsidiary of BGI Group Will Distribute CleanPlex® NGS Target Enrichment Panels Optimized for Its MGISEQ and BGISEQ Sequencing Platforms in All Territories Outside the U.S.– –Paragon Genomics Will Distribute MGI’s Automated Sample Preparation Systems in the U.S. and Canada with Optimized CleanPlex Chemistries Providing a Complete Automated Solution– HAYWARD, CA – Paragon Genomics, Inc., a […]
Comprehensive pan-cancer tumor profiling assays to be combined with clinical informatics platform with the potential to reduce time, cost, and complexity of clinical genomic analysis ST. LOUIS–PierianDx, a leading clinical genomics informatics company, today announced a strategic, non-exclusive, multi-year partnership with Illumina, Inc. to provide a variant interpretation and reporting solution based on PierianDx’s Clinical Genomics […]
CoreBiome leverages OraSure’s leadership position in microbiome sample collection with end-to-end laboratory services for sample processing, sequencing, and bioinformatics Novosanis’ urine collection technology expands molecular collection portfolio and advances OraSure’s expertise in non-invasive sampling BETHLEHEM, Pa. — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, today […]
San Francisco, Jan. 4, 2019: SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data- Driven Medicine. The round was led by Generation Investment Management, a pioneer of sustainable investing, with offices in London and San Francisco. Generation were joined by Idinvest Partners, […]
MADISON, Wis.–Promega Corporation’s latest microsatellite instability (MSI) technology has been granted innovation designation by the Chinese National Medical Products Administration (NMPA). Promega MSI technology has been validated in labs around the world. With innovation status, the path to become classified as an invitro diagnostic (IVD) will gain elevated efficiency by having a program coordinator assigned […]
LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the assets of the Edmonton-based Delta Genomics Centre — a major animal genomics laboratory in Canada. With the acquisition, Delta’s laboratory operations will be renamed Neogen Canada, and become Neogen’s fifth animal genomics laboratory — joining locations in the U.S., Scotland, Brazil, […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
